No abstract

No abstract

No abstract

[1] Although most Central American magmas have a typical arc geochemical signature, magmas in southern Central America (central Costa Rica and Panama) have isotopic and trace element compositions with an ocean island basalt (OIB) affinity, similar to the Galapagos-OIB lavas (e.g., Ba/La < 40, La/Yb > 10, 206 Pb/ 204 Pb > 18.8). Our new data for Costa Rica suggest that this signature, unusual for a convergent margin, has a relatively recent origin (Late Miocene $6 Ma). We also show that there was a transition from typical arc magmas (analogous to the modern Nicaraguan volcanic front) to OIB-like magmas similar to the Galapagos hot spot. The geographic distribution of the Galapagos signature in recent lavas from southern Central America is present landward from the subduction of the Galapagos hot spot tracks (the Seamount Province and the Cocos/Coiba Ridge) at the Middle American Trench. The higher Pb isotopic ratios, relatively lower Sr and Nd isotopic ratios, and enriched incompatible-element signature of central Costa Rican magmas can be explained by arc-hot spot interaction. The isotopic ratios of central Costa Rican lavas require the subducting Seamount Province (Northern Galapagos Domain) component, whereas the isotopic ratios of the adakites and alkaline basalts from southern Costa Rica and Panama are in the geochemical range of the subducting Cocos/Coiba Ridge (Central Galapagos Domain). Geological and geochemical evidence collectively indicate that the relatively recent Galapagos-OIB signature in southern Central America represents a geochemical signal from subducting Galapagos hot spot tracks, which started to collide with the margin $8 Ma ago. The Galapagos hot spot contribution decreases systematically along the volcanic front from central Costa Rica to NW Nicaragua.

This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution and sharing with colleagues. Other uses, including reproduction and distribution, or selling or licensing copies, or posting to personal, institutional or third party websites are prohibited. In most cases authors are permitted to post their version of the article (e.g. in Word or Tex form) to their personal website or institutional repository. Authors requiring further information regarding Elsevier's archiving and manuscript policies are encouraged to visit: http://www.elsevier.com/copyright